Private Versus Public Sector Insurance Coverage for Drug Abuse

by Jeannette Rogowski


Download eBook for Free

FormatFile SizeNotes
PDF file 2.6 MB

Use Adobe Acrobat Reader version 10 or higher for the best experience.


Purchase Print Copy

 FormatList Price Price
Add to Cart Paperback70 pages $13.00 $10.40 20% Web Discount

This study examined financing mechanisms currently in place for treating drug abuse, focusing primarily on differences between private and public insurance mechanisms. Within the private sector, insurance coverage for drug abuse treatment is quite restrictive. Limitations typically exist on the type and amount of treatment that can be received per year or per lifetime, and benefits may quickly be exhausted. Limitations also exist with regard to public insurance funding. Eligibility requirements and the authorized settings in which care may be provided are extremely restrictive. It has been argued that public funding for drug abuse should be mainstreamed into Medicaid. However, this is not likely to occur due to significant institutional barriers, and in particular to the highly restrictive eligibility requirements for public programs.

This report is part of the RAND Corporation monograph report series. The monograph/report was a product of the RAND Corporation from 1993 to 2003. RAND monograph/reports presented major research findings that addressed the challenges facing the public and private sectors. They included executive summaries, technical documentation, and synthesis pieces.

Permission is given to duplicate this electronic document for personal use only, as long as it is unaltered and complete. Copies may not be duplicated for commercial purposes. Unauthorized posting of RAND PDFs to a non-RAND Web site is prohibited. RAND PDFs are protected under copyright law. For information on reprint and linking permissions, please visit the RAND Permissions page.

The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.